We are live on
!
Find out more
NVPX
Norwest Venture Partners XII Portfolio holdings
AUM
$75.4M
1-Year Est. Return
53.35%
This Fund
S&P 500
This Quarter
Est. Return
-68.22%
1 Year Est. Return
-53.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.32M
AUM Growth
-$94.1M
(-92%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-1,055.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSPR
Casper Sleep Inc.
CSPR
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Health Catalyst
HCAT
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 100% |
| 2 | Healthcare | 0% |
Similar funds
FFMBT
WM
SMC
RA
RC
PM
GI
PIMH
Norwest Venture Partners XII's Q1 2020 Portfolio in Review
As of Q1 2020, Norwest Venture Partners XII held 2 positions worth $8.32M, down 92% from $102M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Norwest Venture Partners XII withdrew a net $87.8M in Q1 2020, closing 1 position. Its most notable exit was Health Catalyst, an estimated $102M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 100% of assets, followed by Healthcare.
Against the trend, Norwest Venture Partners XII opened a new position in Casper Sleep Inc. worth $8.32M.
- Norwest Venture Partners XII's largest Q1 2020 buy was Casper Sleep Inc.: 1,940,576 shares worth $8.32M.
- Norwest Venture Partners XII fully exited Health Catalyst in Q1 2020, selling an estimated $102M.
- Norwest Venture Partners XII's ten largest holdings make up 100% of its $8.32M portfolio in Q1 2020.
- Norwest Venture Partners XII opened 1 new position and closed 1 in Q1 2020.
- Norwest Venture Partners XII's portfolio value fell 92% quarter-over-quarter to $8.32M.
Based on Norwest Venture Partners XII's 13F filing for Q1 2020, filed 10 Apr 2020.